
Dr. Kristin Kohler recently joined ASCO's JCO Precision Oncology Conversations with her co-authors to share insights from "Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk." These findings provide new insights into the molecular and clinical heterogeneity of germline deletions involving EPCAM. Listen now: hubs.ly/Q04FfbbG0


















